These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29088253)

  • 1. A composite docking approach for the identification and characterization of ectosteric inhibitors of cathepsin K.
    Law S; Panwar P; Li J; Aguda AH; Jamroz A; Guido RVC; Brömme D
    PLoS One; 2017; 12(10):e0186869. PubMed ID: 29088253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone.
    Panwar P; Law S; Jamroz A; Azizi P; Zhang D; Ciufolini M; Brömme D
    Br J Pharmacol; 2018 Mar; 175(6):902-923. PubMed ID: 29278432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of substrate-specific inhibitors of cathepsin K through high-throughput screening.
    Law S; Du X; Panwar P; Honson NS; Pfeifer T; Roberge M; Brömme D
    Biochem J; 2019 Feb; 476(3):499-512. PubMed ID: 30622151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Ectosteric Inhibitor of Cathepsin K Inhibits Bone Resorption in Ovariectomized Mice.
    Panwar P; Xue L; Søe K; Srivastava K; Law S; Delaisse JM; Brömme D
    J Bone Miner Res; 2017 Dec; 32(12):2415-2430. PubMed ID: 28745432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green asymmetric synthesis of epoxypeptidomimetics and evaluation as human cathepsin K inhibitors.
    Silva TL; Dos Santos DA; de Jesus HCR; Brömme D; Fernandes JB; Paixão MW; Corrêa AG; Vieira PC
    Bioorg Med Chem; 2020 Aug; 28(15):115597. PubMed ID: 32631567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy.
    Mukherjee K; Chattopadhyay N
    Biochem Pharmacol; 2016 Oct; 117():10-9. PubMed ID: 27106079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate selectively inhibits the collagenase activity of cathepsin K.
    Zhang X; Luo Y; Hao H; Krahn JM; Su G; Dutcher R; Xu Y; Liu J; Pedersen LC; Xu D
    Matrix Biol; 2024 May; 129():15-28. PubMed ID: 38548090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K.
    Panwar P; Søe K; Guido RV; Bueno RV; Delaisse JM; Brömme D
    Br J Pharmacol; 2016 Jan; 173(2):396-410. PubMed ID: 26562357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mild Inhibition of Cathepsin K Paradoxically Stimulates the Resorptive Activity of Osteoclasts in Culture.
    Pirapaharan DC; Søe K; Panwar P; Madsen JS; Bergmann ML; Overgaard M; Brömme D; Delaisse JM
    Calcif Tissue Int; 2019 Jan; 104(1):92-101. PubMed ID: 30194476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor.
    Sharma V; Panwar P; O'Donoghue AJ; Cui H; Guido RV; Craik CS; Brömme D
    Biochem J; 2015 Jan; 465(1):163-73. PubMed ID: 25279554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the discovery of cathepsin K inhibitors on bone resorption.
    Lu J; Wang M; Wang Z; Fu Z; Lu A; Zhang G
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):890-904. PubMed ID: 29723068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dioxo-triazines as a novel series of cathepsin K inhibitors.
    Rankovic Z; Cai J; Fradera X; Dempster M; Mistry A; Mitchell A; Long C; Hamilton E; King A; Boucharens S; Jamieson C; Gillespie J; Cumming I; Uitdehaag J; van Zeeland M
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1488-90. PubMed ID: 20153187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin K inhibitors for osteoporosis and potential off-target effects.
    Brömme D; Lecaille F
    Expert Opin Investig Drugs; 2009 May; 18(5):585-600. PubMed ID: 19388876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of basic amino acid surface clusters on the collagenase activity of cathepsin K.
    Nallaseth FS; Lecaille F; Li Z; Brömme D
    Biochemistry; 2013 Nov; 52(44):7742-52. PubMed ID: 24088021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711.
    Lindström E; Rizoska B; Henderson I; Terelius Y; Jerling M; Edenius C; Grabowska U
    J Transl Med; 2018 May; 16(1):125. PubMed ID: 29743078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity.
    Lemke C; Benýšek J; Brajtenbach D; Breuer C; Jílková A; Horn M; Buša M; Ulrychová L; Illies A; Kubatzky KF; Bartz U; Mareš M; Gütschow M
    J Med Chem; 2021 Sep; 64(18):13793-13806. PubMed ID: 34473502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat.
    Lark MW; Stroup GB; James IE; Dodds RA; Hwang SM; Blake SM; Lechowska BA; Hoffman SJ; Smith BR; Kapadia R; Liang X; Erhard K; Ru Y; Dong X; Marquis RW; Veber D; Gowen M
    Bone; 2002 May; 30(5):746-53. PubMed ID: 11996914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K.
    Mons E; Jansen IDC; Loboda J; van Doodewaerd BR; Hermans J; Verdoes M; van Boeckel CAA; van Veelen PA; Turk B; Turk D; Ovaa H
    J Am Chem Soc; 2019 Feb; 141(8):3507-3514. PubMed ID: 30689386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.
    Stroup GB; Lark MW; Veber DF; Bhattacharyya A; Blake S; Dare LC; Erhard KF; Hoffman SJ; James IE; Marquis RW; Ru Y; Vasko-Moser JA; Smith BR; Tomaszek T; Gowen M
    J Bone Miner Res; 2001 Oct; 16(10):1739-46. PubMed ID: 11585335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hurdles in the drug discovery of cathepsin K inhibitors.
    Kometani M; Nonomura K; Tomoo T; Niwa S
    Curr Top Med Chem; 2010; 10(7):733-44. PubMed ID: 20337584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.